Investorideas.com Newswire

Investorideas.com Newswire
Be one of the most talked about companies (stocks) on social media

Investorideas.com newswire, biotech stocks and industry

Tuesday, July 27, 2010

Investorideas.com - Leading Sector Biotech Stocks; OTC Volume Leaders; Most Active ($1.00-$2.00): (OTCBB: EMIS), (OTCBB: SILA), (OTCBB: NNVC), (OTCBB: NWBO)

Investorideas.com - Leading Sector Biotech Stocks; OTC Volume Leaders; Most Active ($1.00-$2.00): (OTCBB: EMIS), (OTCBB: SILA), (OTCBB: NNVC), (OTCBB: NWBO)


Leading Sector Biotech Stocks; OTC Volume Leaders; Most Active ($1.00-$2.00): (OTCBB: EMIS), (OTCBB: SILA), (OTCBB: NNVC), (OTCBB: NWBO)
Note to Editors: The Following Is an Investment Opinion Being Issued by OTC VOLUME LEADERS


Category: Investment, Financial
Subscribe to Investor Ideas Newswire
Visit this company: www.otcvolumeleaders.com
Point Roberts, WA (Investorideas.com Newswire) July 27, 2010 - OTC VOLUME LEADERS reports on the most active trading stocks on the OTCBB. OTC Volume leaders ($1.00-$2.00) include Emisphere Technologies, Inc. (OTCBB: EMIS), Gold American Mining Corp. (OTCBB: SILA), NanoViricides, Inc. (OTCBB: NNVC), and Northwest Biotherapeutics Inc. (OTCBB: NWBO).


Sign up for Free OTC Volume Leader Alerts!http://bit.ly/otcvolumeleaders


OTC / Market Commentary:
Sectors include Biotech Stocks
One of the OTCBB volume leaders: NanoViricides, Inc. (OTCBB: NNVC)"NanoViricides, Inc. (www.nanoviricides.com) is a development stage company that is creating special purpose nanomaterials for viral therapy. The Company's novel nanoviricide™ class of drug candidates are designed to specifically attack enveloped virus particles and to dismantle them. The Company is developing drugs against a number of viral diseases including H1N1 swine flu, H5N1 bird flu, seasonal Influenza, HIV, oral and genital Herpes, viral diseases of the eye including EKC and herpes keratitis, Hepatitis C, Rabies, Dengue fever, and Ebola virus, among others."

Market Snapshot: (at time of release)
Dow 10,553.66 +28.23 +0.27%
Nasdaq 2,292.24 -4.19 -0.18%
S&P 500 1,115.46 +0.45 +0.04%
10 Yr Bond(%) 3.0520% +0.5800
Oil 77.62 -1.36 -1.72%
Gold 1,162.80 -20.20 -1.71%

OTCBB Investors: Take the few minutes to register with us at To sign up for free Newsletter http://bit.ly/otcvolumeleaders and get access to info on hundreds of the most active OTCBB companies and keep up to date with developments of the companies.



OTC VOLUME LEADERS provides investors with daily market updates showcasing the most actively traded OTCBB Companies. We strive to provide you with the most up-to-date market information and activity by searching through hundreds of OTCBB companies in order to provide you information on the best of these companies. The goal is to continually find tomorrow’s market leading companies, today!
OTCVolumeleaders.com has not been compensated by any of the above mentioned companies. We act as an independent research portal and are aware that all investment entails inherent risks.
Please view the full disclaimer: http://www.otcvolumeleaders.com/Source http://www.otcvolumeleaders.com/Follow OTC Volume Leaders on Twitter.com http://twitter.com/OTCVolumeLeader
Visit the OTC showcase profile at Investorideas.com Request News and Info on OTC Disclosure, Disclaimer/ OTC is a paid advertising client on Investorideas.com.
More Info:
Published at www.Investorideas.com - Global research by sectors
If you have any questions regarding information in this press release please contact the company listed in the press release.
Disclaimer: The following news is paid for and /or published as information only for our readers. Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.aspInvestorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp

No comments:

Post a Comment